Effects of combination therapy consisting of moderate-dose intravenous immunoglobulin G, pulsed methylprednisolone and pravastatin in children with steroid-resistant nephrosis.
Kano
K
K
Hoshi
E
E
Ito
S
S
Kyo
K
K
Yamada
Y
Y
Ando
T
T
Arisaka
O
O
Tomita
S
S
Ueda
Y
Y
D000924:Anticholesteremic Agents / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D007223:Infant; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage*; D009404:Nephrotic Syndrome / Q000188:drug therapy* / Q000628:therapy*; D017035:Pravastatin / Q000008:administration & dosage*
D000924:Anticholesteremic Agents; D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D017035:Pravastatin; D008775:Methylprednisolone